PROVIDER SERVICE NETWORKS FOR PHARMACIST CONTRACTING SHOULD BE ALLOWED BY FTC, APhA PRESIDENT ARGUES; KNOWLTON AND HOSCHEIT ADDRESS DECLINING MARGINS
Pharmacists should be able to join together to refuse third-party reimbursement schemes that they view as inadequate, American Pharmaceutical Association President Calvin Knowlton, PhD, argued in comments to the Federal Trade Commission at a Nov. 8 hearing on the effect of "the changing nature of competition in a global and innovation-driven age" on small business.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth